| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Common Stock | +Options Exercise | $380,200 | +4,000 | +10.64% | $95.05 | 41,611 | Sep 1, 2023 | Direct | |
| transaction | EOG | Common Stock | -Disposed to Issuer | -$380,246 | -2,916 | -7.01% | $130.40 | 38,695 | Sep 1, 2023 | Direct | |
| transaction | EOG | Common Stock | -Tax liability | -$34,426 | -264 | -0.68% | $130.40 | 38,431 | Sep 1, 2023 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Stock Appreciation Rights | -Options Exercise | $0 | -4,000 | -100% | $0.00 | 0 | Sep 1, 2023 | Common Stock | 4,000 | $95.05 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The SARs granted, which were scheduled to expire on September 29, 2023, became exercisable in 25 percent increments beginning one year from the September 29, 2016 date of grant and on each of the next three grant date anniversaries. The SARs granted became fully exercisable on September 29, 2020. This exercise did not involve any open-market sale of the Issuer's Common Stock. |